CRYSTAL STRUCTURES OF BACTERIAL RIBULOSE-PHOSPHATE 3-EPIMERASES

The present invention relates to novel drug targets for pathogenic bacteria. Accordingly, the invention provides purified protein comprising the amino acid sequence set forth in SEQ ID NO: 4. The invention also provides biochemical and biophysical characteristics of the polypeptides of the invention...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	VEDADI, MASOUD, PINDER, BENJAMIN, NETHERY, KATHLEEN, CLARKE, TERESA, DOMAGALA, MEGAN, KIMBER, MATTHEW, DHARAMSI, AKIL, ALAM, MUHAMMAD, ZAHOOR, EDWARDS, ALED, HOUSTON, SIMON
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	AFTER-TREATMENT OF SINGLE CRYSTALS OR A HOMOGENEOUSPOLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE APPARATUS THEREFOR BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CRYSTAL GROWTH CULTURE MEDIA ENZYMOLOGY METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PEPTIDES PRODUCTION OF A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITHDEFINED STRUCTURE PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS REFINING BY ZONE-MELTING OF MATERIAL SINGLE CRYSTALS OR HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITHDEFINED STRUCTURE SINGLE-CRYSTAL-GROWTH SPIRITS UNIDIRECTIONAL SOLIDIFICATION OF EUTECTIC MATERIAL ORUNIDIRECTIONAL DEMIXING OF EUTECTOID MATERIAL VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present invention relates to novel drug targets for pathogenic bacteria. Accordingly, the invention provides purified protein comprising the amino acid sequence set forth in SEQ ID NO: 4. The invention also provides biochemical and biophysical characteristics of the polypeptides of the invention. La présente invention concerne de nouvelles cibles de médicaments pour les bactéries pathogènes. L'invention concerne donc une protéine purifiée contenant la séquence d'acide aminé incluse dans SEQ ID NO: 4. L'invention concerne également des caractéristiques biochimiques ou biophysiques des polypeptides de l'invention.